Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HNF4A | P41235 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | RXRA | P19793 | 7/20 | 0.34 |
| ▸ | RARA | P10276 | 7/20 | 0.34 |
| ▸ | RARB | P10826 | 6/20 | 0.34 |
| ▸ | RARG | P13631 | 5/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | RXRB | P28702 | 3/20 | 0.33 |
| ▸ | RXRG | P48443 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9077794 | 0.79 | HNF4A (0.40) | HNF4ACYP1A2TP53RXRARARA | |
| SCHEMBL24604253 | 0.78 | — | — | |
| SCHEMBL9215514 | 0.76 | CYP1A2 (0.46) | HNF4ACYP1A2TP53RXRARARA | |
| SCHEMBL27033882 | 0.76 | HNF4A (0.35) | HNF4ACYP1A2TP53RXRARARA | |
| SCHEMBL6261249 | 0.76 | TAAR1 (0.38) | CYP1A2TP53RXRARARARARB | |
| SCHEMBL24701551 | 0.73 | HNF4A (0.33) | HNF4ACYP1A2TP53RXRARARA | |
| SCHEMBL9217192 | 0.73 | ACHE (0.42) | HNF4ACYP1A2TP53RXRARARA | |
| SCHEMBL4666966 | 0.68 | RXRA (0.44) | RXRARARARARBRARGRXRB | |
| SCHEMBL24055390 | 0.68 | HNF4A (0.38) | HNF4ACYP1A2TP53RXRARARA | |
| SCHEMBL31106548 | 0.68 | HNF4A (0.38) | HNF4ACYP1A2TP53RXRARARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220393115-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220393115-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | LEF1, L1CAM, PIEZO1 | HNF4A 1709/4885CYP1A2 1171/4885TP53 3558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.